Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Bianchi

Showing results (81-90 of 426) with videos related to

Pageof 43
Sort By:
The Journal of Dermatological Treatment|May 19, 2020
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigmaCaterina Lanna, Claudia Galluzzi, Arianna Zangrilli, et al.
Dermatologic Therapy|April 11, 2019
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solutionLaura Diluvio, Caterina Lanna, Flavia Lozzi, et al.
Dermatologic Therapy|August 30, 2021
Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti-TNF and anti-interleukin-17 failuresRaffaele Dante Caposiena Caro, Chiara Pensa, Sara Lambiase, et al.
International Journal of Dermatology|August 25, 2021
Skin advanced glycation end products as a diagnostic and monitoring tool among psoriatic patients: how the therapy helps reduce cardiovascular disease riskCaterina Lanna, Arianna Zangrilli, Mauro Bavetta, et al.
The British Journal of Dermatology|December 13, 2024
Comment on 'A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council': a case of rhabdomyolysis induced by upadacitinibEdoardo Mortato, Marina Talamonti, Claudia Paganini, et al.
Dermatologic Therapy|February 9, 2022
Coesisting inflammatory skin diseases: Tildrakizumab to control psoriasis and omalizumab for urticariaLaura Diluvio, Chiara Pensa, Arianna Piccolo, et al.
Skin Appendage Disorders|September 9, 2020
Reflectance Confocal Microscopy Applied to Folliculitis Decalvans: Preliminary Results of a Multicenter StudySara Mazzilli, Laura Vollono, Francesco Tassone, et al.
Photodermatology, Photoimmunology & Photomedicine|May 21, 2020
Good things come to those who wait: Successful response of solar urticaria to omalizumab after 1 year of treatmentLaura Vollono, Luca Bianchi, Arianna Piccolo, et al.
Dermatologic Therapy|October 16, 2018
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter creamLaura Diluvio, Mauro Bavetta, Gaetana Costanza, et al.
Drug Design, Development and Therapy|September 19, 2017
New insight into the pathogenesis of nail psoriasis and overview of treatment strategiesAlessandra Ventura, Mauro Mazzeo, Roberta Gaziano, et al.
Pageof 43

Showing results (81-90 of 426) with videos related to

Sort By:
Pageof 43
The Journal of Dermatological Treatment|May 19, 2020
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigmaCaterina Lanna, Claudia Galluzzi, Arianna Zangrilli, et al.
Dermatologic Therapy|April 11, 2019
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solutionLaura Diluvio, Caterina Lanna, Flavia Lozzi, et al.
Dermatologic Therapy|August 30, 2021
Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti-TNF and anti-interleukin-17 failuresRaffaele Dante Caposiena Caro, Chiara Pensa, Sara Lambiase, et al.
International Journal of Dermatology|August 25, 2021
Skin advanced glycation end products as a diagnostic and monitoring tool among psoriatic patients: how the therapy helps reduce cardiovascular disease riskCaterina Lanna, Arianna Zangrilli, Mauro Bavetta, et al.
The British Journal of Dermatology|December 13, 2024
Comment on 'A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council': a case of rhabdomyolysis induced by upadacitinibEdoardo Mortato, Marina Talamonti, Claudia Paganini, et al.
Dermatologic Therapy|February 9, 2022
Coesisting inflammatory skin diseases: Tildrakizumab to control psoriasis and omalizumab for urticariaLaura Diluvio, Chiara Pensa, Arianna Piccolo, et al.
Skin Appendage Disorders|September 9, 2020
Reflectance Confocal Microscopy Applied to Folliculitis Decalvans: Preliminary Results of a Multicenter StudySara Mazzilli, Laura Vollono, Francesco Tassone, et al.
Photodermatology, Photoimmunology & Photomedicine|May 21, 2020
Good things come to those who wait: Successful response of solar urticaria to omalizumab after 1 year of treatmentLaura Vollono, Luca Bianchi, Arianna Piccolo, et al.
Dermatologic Therapy|October 16, 2018
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter creamLaura Diluvio, Mauro Bavetta, Gaetana Costanza, et al.
Drug Design, Development and Therapy|September 19, 2017
New insight into the pathogenesis of nail psoriasis and overview of treatment strategiesAlessandra Ventura, Mauro Mazzeo, Roberta Gaziano, et al.
Pageof 43